ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Xvivo Perfusion AB (PK)

Xvivo Perfusion AB (PK) (XVIPF)

29,39
0,00
(0,00%)
Fermé 07 Juin 10:00PM

Xvivo Perfusion AB (PK) (XVIPF) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
29,39
( - )
Prix Achat
28,99
Prix Vente
30,42
Volume échangé
-
0,00 Fourchette du Jour 0,00
16,975 Plage de 52 semaines 30,95
Cap du marché
Clôture Veille
29,39
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
US$ 104 292
Actions en circulation
31 499 470
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
114,3
Bénéfice par action (BPA)
2,34
Chiffre d'affairess (LTM)
834,53M
Bénéfice net (LTM)
73,86M

À propos de Xvivo Perfusion AB (PK)

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers K... Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally. Xvivo Perfusion AB (publ) was incorporated in 1998 and is headquartered in Mölndal, Sweden. Show more

Secteur
Healthcare
Industrie
Medical Equipment & Supplies
Siège social
Mölndal, Sweden
Fondé
1998
Xvivo Perfusion AB (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker XVIPF. Le dernier cours de clôture d'Xvivo Perfusion AB (PK) était de US$29,39. Au cours de la dernière année, les actions de Xvivo Perfusion AB (PK) ont été négociées dans une fourchette de prix de US$ 16,975 à US$ 30,95.

Xvivo Perfusion AB (PK) compte actuellement 31 499 470 actions en circulation. La capitalisation boursière d'Xvivo Perfusion AB (PK) est de US$925,77 million. Xvivo Perfusion AB (PK) a un ratio cours/bénéfice (ratio PE) de 114.30.

XVIPF Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40029.3929.3929.3921629.39CS
126.579228.842478124422.810829.3922.810810125.61377278CS
269.747449.623776893119.642629.3919.1523921.8827741CS
52-0.26-0.87689713322129.6530.9516.97535121.78170729CS
1562.248.2504604051627.1552.376816.97534531.68041716CS
260-12.51-29.856801909341.952.376811.1532830.32959409CS

XVIPF - Frequently Asked Questions (FAQ)

What is the current Xvivo Perfusion AB (PK) share price?
The current share price of Xvivo Perfusion AB (PK) is US$ 29,39
How many Xvivo Perfusion AB (PK) shares are in issue?
Xvivo Perfusion AB (PK) has 31 499 470 shares in issue
What is the market cap of Xvivo Perfusion AB (PK)?
The market capitalisation of Xvivo Perfusion AB (PK) is USD 925,77M
What is the 1 year trading range for Xvivo Perfusion AB (PK) share price?
Xvivo Perfusion AB (PK) has traded in the range of US$ 16,975 to US$ 30,95 during the past year
What is the PE ratio of Xvivo Perfusion AB (PK)?
The price to earnings ratio of Xvivo Perfusion AB (PK) is 114,3
What is the cash to sales ratio of Xvivo Perfusion AB (PK)?
The cash to sales ratio of Xvivo Perfusion AB (PK) is 10,11
What is the registered address of Xvivo Perfusion AB (PK)?
The registered address for Xvivo Perfusion AB (PK) is Gemenskapens gata 9, Mölndal, Västra Götaland County, 431 53
What is the Xvivo Perfusion AB (PK) website address?
The website address for Xvivo Perfusion AB (PK) is www.xvivogroup.com
Which industry sector does Xvivo Perfusion AB (PK) operate in?
Xvivo Perfusion AB (PK) operates in the Medical Equipment & Supplies sector

XVIPF Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion